The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 04, 2006

Filed:

Apr. 18, 2003
Applicants:

Anthony Cerami, Shelter Island, NY (US);

Peter C. Ulrich, Old Tappan, NJ (US);

Dilip R. Wagle, Valley Cottage, NY (US);

San-bao Hwang, Sudbury, MA (US);

Sara Vasan, Yonkers, NY (US);

John J. Egan, Mountain Lakes, NJ (US);

Inventors:

Anthony Cerami, Shelter Island, NY (US);

Peter C. Ulrich, Old Tappan, NJ (US);

Dilip R. Wagle, Valley Cottage, NY (US);

San-Bao Hwang, Sudbury, MA (US);

Sara Vasan, Yonkers, NY (US);

John J. Egan, Mountain Lakes, NJ (US);

Assignee:

Alteon, Inc., Parsippany, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/426 (2006.01); C07D 277/20 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to compositions and methods for inhibiting and reversing nonenzymatic cross-linking (protein aging). Accordingly, compositions are disclosed which comprise an agent capable of inhibiting the formation of advanced glycosylation endproducts of target proteins, and which additionally reverse pre-formed crosslinks in the advanced glycosylation endproducts by cleaving alpha-dicarbonyl-based protein crosslinks present in the advanced glycosylation endproducts. Certain useful agents are thiazolium salts. The method comprises contacting the target protein with the composition. Both industrial and therapeutic applications for the invention are envisioned, as food spoilage and animal protein aging can be treated. A novel immunoassay for detection of the reversal of the nonenzymatic crosslinking is also disclosed.


Find Patent Forward Citations

Loading…